Navigation Links
China-Biotics Ranked Number 62 on FORTUNE'S 100 Fastest-Growing Companies' List
Date:8/26/2010

China-Biotics Ranked Number 62 on FORTUNE'S 100 Fastest-Growing Companies' List -- SHANGHAI, Aug. 26 /PRNewswire-Asia-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Pharmaceuticals, Awards Click to view news release full screen  

China-Biotics Ranked Number 62 on FORTUNE'S 100 Fastest-Growing Companies' List

 

SHANGHAI, Aug. 26 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics," the "Company") (Nasdaq: CHBT), a leading developer, manufacturer and distributor of probiotics products in China, today announced that the Company is ranked 62nd on FORTUNE's 2010 "Fastest-Growing Companies" list.

FORTUNE'S 100 Fastest-Growing Companies list includes foreign and domestic companies traded on a major U.S. stock exchange with annual revenue and net income of at least $50 million and $10 million, respectively, a market capitalization over $250 million, and significant revenue and earnings growth over recent quarters, among other criteria.

Mr. Jinan Song, Chairman and Chief Executive Officer of China-Biotics, commented, "We are honored to have been distinguished by FORTUNE as one of this year's 100 Fastest-Growing Companies. The long-term growth prospect of our business model is gaining traction within the global professional investment community. In a recent speech, Minister of Health of China, Mr. Zhu Chen, emphasized the need to minimize the excessive reliance on antibiotics. The government has endorsed the use of probiotics as an alternative. We believe probiotics present a viable long-term solution to address the antibiotics overuse while simultaneously improving the Chinese people's overall health level."

The related stories appear in the September 6, 2010 issue of FORTUNE, available on newsstands on Monday, August 23rd or through the internet at: http://money.cnn.com/magazines/fortune/fortunefastestgrowing/2010/full_list/

About China-Biotics

China-Biotics, Inc. ("China-Biotics," the "Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company develops and produces its proprietary product portfolio, including live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com .

Safe Harbor Statement

The information in this release contains forward-looking statements which involve risks and uncertainties, including statements regarding the Company's capital needs, business strategy and expectations. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements, which may be identified by terminology such as "may," "should," "will," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," "potential," "forecast," "project," "continue," or the negative of such terms or other comparable terminology. Readers should not rely on forward-looking statements as predictions of future events or results. Any or all of the Company's forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions, risks and uncertainties and other factors which could cause actual events or results to be materially different from those expressed or implied in the forward-looking statements. In evaluating these statements, readers should consider various factors, including the risks described in "Item 1A. Risk Factors" beginning on page 17 and elsewhere in the Company's 2010 Annual Report on Form 10-K. These factors may cause the Company's actual results to differ materially from any forward-looking statement. In addition, new factors emerge from time to time and it is not possible for the Company to predict all factors that may cause actual results to differ materially from those contained in any forward-looking statements. The Company disclaims any obligation to publicly update any forward-looking statements to reflect events or circumstances after the date of this document, except as required by applicable law.

For more information, please contact: Travis Cai Chief Financial Officer China-Biotics, Inc. Email: traviscai@chn-biotics.com Shiwei Yin/Kevin Theiss Grayling Phone: +1-646-284-9474 Email: shiwei.yin@grayling.com kevin.theiss@grayling.com
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics to Report Fiscal Year 2011 First Quarter Financial Results on August 9
2. China-Biotics Provides Further Updates on Qingpu New Facility
3. China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
4. China-Biotics to Report Fourth Quarter and Fiscal Year 2010 Financial Results on June 11
5. China-Biotics to Present at Bank of America Merrill Lynch Healthcare Event on June 22
6. China-Biotics Provides Updates on Qingpu New Facility and Chinese Probiotics Market
7. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
8. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
9. China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
10. China-Biotics, Inc. Announces Conference Call to Discuss Second Quarter Fiscal 2010 Financial Results
11. China-Biotics, Inc. Appoints New Vice President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Ginkgo Bioworks , a leading organism design company ... as one of the World Economic Forum,s Technology ... companies. Ginkgo Bioworks is engineering biology to manufacture ... the nutrition, health and consumer goods sectors. The ... Fortune 500 companies to design microbes for their ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry Network for ... Design Lab . Located in Pasadena, Calif., the Design Lab’s mission is to ... are designed, built and brought to market. , The Design Lab is Supplyframe’s ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... implemented as a compact web-based "all-in-one" system solution for ... biometric fingerprint reader or the door interface with integration ... modern access control systems. The minimal dimensions of the ... readers into the building installations offer considerable freedom of ...
(Date:4/14/2016)... Israel , April 14, 2016 ... Authentication and Malware Detection, today announced the appointment of ... assumed the new role. Goldwerger,s leadership appointment ... on the heels of the deployment of its platform ... BioCatch,s behavioral biometric technology, which discerns unique cognitive and ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
Breaking Biology News(10 mins):